Your browser doesn't support javascript.
loading
Vaccination with poly(D,L-lactide-co-glycolide) nanoparticles loaded with soluble Leishmania antigens and modified with a TNFα-mimicking peptide or monophosphoryl lipid A confers protection against experimental visceral leishmaniasis.
Margaroni, Maritsa; Agallou, Maria; Athanasiou, Evita; Kammona, Olga; Kiparissides, Costas; Gaitanaki, Catherine; Karagouni, Evdokia.
Afiliação
  • Margaroni M; Laboratory of Cellular Immunology, Department of Microbiology, Hellenic Pasteur Institute.
  • Agallou M; Department of Animal and Human Physiology, School of Biology, National and Kapodistrian University of Athens, Athens.
  • Athanasiou E; Laboratory of Cellular Immunology, Department of Microbiology, Hellenic Pasteur Institute.
  • Kammona O; Laboratory of Cellular Immunology, Department of Microbiology, Hellenic Pasteur Institute.
  • Kiparissides C; Chemical Process & Energy Resources Institute, Centre for Research and Technology Hellas.
  • Gaitanaki C; Chemical Process & Energy Resources Institute, Centre for Research and Technology Hellas.
  • Karagouni E; Department of Chemical Engineering, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Int J Nanomedicine ; 12: 6169-6184, 2017.
Article em En | MEDLINE | ID: mdl-28883727
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nanopartículas / Vacinas contra Leishmaniose / Leishmaniose Visceral Limite: Animals Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nanopartículas / Vacinas contra Leishmaniose / Leishmaniose Visceral Limite: Animals Idioma: En Ano de publicação: 2017 Tipo de documento: Article